Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca(2+) influx and induces streamers

Eur J Immunol. 2011 Aug;41(8):2436-46. doi: 10.1002/eji.201041204. Epub 2011 Jul 4.

Abstract

We have reported that during complement-mediated cytolysis of B cells promoted by the CD20 mAbs rituximab or ofatumumab (OFA), long, thin structures that we call streamers (≥ 3 cell diameters) are rapidly generated and grow out from the cell surface. Streamers appear before cells are killed and contain opsonizing mAbs and membrane lipids. By exploiting the differential Ca(2+) requirements of discrete steps in the complement cascade, we determined that mAb-opsonized cells first tagged with C3b using C5-depleted serum are killed on addition of serum and EDTA, but the cells do not produce streamers. Also, cells first opsonized with OFA are lysed in serum containing Mg-EGTA by the alternative complement pathway but streamers are not produced. These findings indicate that Ca(2+) influx is necessary for streamer formation. Other mAbs that promote complement-mediated cytolysis also induce streamers on target cells. Streamer-like structures called nanotubes have been reported in several cellular systems, and are thought to promote intercellular communication/signaling. We tested whether this signaling could influence the susceptibility of neighboring cells contacted by streamers to complement attack and found that complement-mediated cytolysis of OFA-opsonized cells increases the resistance of unopsonized indicator cell populations to subsequent lysis when these cells are exposed to OFA and complement.

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived / immunology
  • Antigens, CD20 / immunology
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • CD55 Antigens / immunology
  • CD55 Antigens / metabolism
  • Calcium / antagonists & inhibitors
  • Calcium / immunology*
  • Calcium / metabolism
  • Cell Line
  • Cell Line, Tumor
  • Chelating Agents / pharmacology
  • Complement Activation / immunology
  • Complement C3b / immunology
  • Complement C3b / metabolism
  • Complement C5 / immunology
  • Complement C5 / metabolism
  • Complement Membrane Attack Complex / immunology*
  • Complement Membrane Attack Complex / metabolism
  • Complement Pathway, Alternative / immunology
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / immunology*
  • Egtazic Acid / pharmacology
  • Flow Cytometry
  • Humans
  • Leukocyte Common Antigens / immunology
  • Leukocyte Common Antigens / metabolism
  • Melitten / pharmacology
  • Microscopy, Fluorescence
  • Phosphatidylserines / immunology
  • Phosphatidylserines / metabolism
  • Rituximab
  • Serum / immunology
  • Serum / metabolism

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • CD55 Antigens
  • Chelating Agents
  • Complement C5
  • Complement Membrane Attack Complex
  • Phosphatidylserines
  • Melitten
  • Rituximab
  • Egtazic Acid
  • Complement C3b
  • Leukocyte Common Antigens
  • ofatumumab
  • Calcium